[Federal Register Volume 79, Number 49 (Thursday, March 13, 2014)]
[Notices]
[Page 14296]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-05480]



[[Page 14296]]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration; GE 
Healthcare

    By Notice dated November 2, 2013, and published in the Federal 
Register on November 19, 2013, 78 FR 69447, GE Healthcare, 3350 North 
Ridge Avenue, Arlington Heights, Illinois 60004-1412, made application 
by renewal to the Drug Enforcement Administration (DEA) to be 
registered as an importer of Cocaine (9041), a basic class of 
controlled substance listed in schedule II.
    The company plans to import small quantities of ioflupane, in the 
form of three separate analogues of Cocaine, that will be used for the 
support and manufacture of DaTSCAN (ioflupane I-123) injections for 
distribution as a radioactive diagnostic imaging agent utilized in the 
diagnosis of Parkinson's disease.
    No comments or objections have been received. The DEA has 
considered the factors in 21 U.S.C. 823(a) and 952(a), and determined 
that the registration of GE Healthcare to import the basic class of 
controlled substance is consistent with the public interest, and with 
United States obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971. The DEA has investigated GE 
Healthcare to ensure that the company's registration is consistent with 
the public interest. The investigation has included inspection and 
testing of the company's physical security systems, verification of the 
company's compliance with state and local laws, and a review of the 
company's background and history. Therefore, pursuant to 21 U.S.C. 
952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above 
named company is granted registration as an importer of the basic class 
of controlled substance listed.

    Dated: February 19, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2014-05480 Filed 3-12-14; 8:45 am]
BILLING CODE 4410-09-P